Scholar Rock (NASDAQ:SRRK) executives said the company is “poised for a transformative year in 2026,” with its top priority ...

Catalent is cutting more roles at its gene therapy manufacturing facility in Harmans, Maryland. | Catalent is cutting more roles at its gene therapy manufacturing facility in Harmans, Maryland. This ...

CDMO giant Catalent has snapped up a biologics development and manufacturing facility in the U.K. and will shell out $160 million to wrap up construction there. The facility is located near Oxford at ...

The Somerset-based pharmaceutical company announced June 20 that Matti Masanovich will take on the role, effective July 5. He succeeds Thomas Castellano, who left Catalent April 13 after 15 years with ...

It was supposed to be a “win-win”—a rare business deal that would provide a huge boost to both sides. Instead, it is turning into the acquisition that has hit big bumps, with layoffs, productivity ...

The Somerset biopharma company announced the move Aug. 10, just a few weeks after unveiling its new operating structure, not to mention a new CEO, Alessandro Maselli, who started in the position July ...

Catalent trimmed its annual revenue and net income forecasts. The contract drug manufacturer said the cuts were due to operational challenges. Catalent said it continues to add new customers. It seems ...

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better ...

UKRAINE - 2021/05/04: In this Photo illustration a Catalent logo of a pharmaceutical company is seen on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via ...

May 8 (Reuters) - Catalent Inc (CTLT.N), opens new tab expects to cut by more than $400 million both its full-year revenue and core profit forecasts, the contract drug manufacturer said on Monday, ...